- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA
Authors
Keywords
EGFR, HER2, Glioblastoma, Antibodies, monoclonal, humanized, Cetuximab, Trastuzumab, EGFR, HER2, Glioblastom, Monoklonale humane Antikörper, Cetuximab, Trastuzumab
Journal
STRAHLENTHERAPIE UND ONKOLOGIE
Volume 191, Issue 2, Pages 180-191
Publisher
Springer Nature
Online
2014-08-26
DOI
10.1007/s00066-014-0743-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients
- (2014) Henri Wichmann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
- (2014) Sumitra Mohan et al. PLoS Genetics
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110
- (2013) A. Schulte et al. NEURO-ONCOLOGY
- Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis
- (2013) Shen Keren et al. TUMOR BIOLOGY
- Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
- (2012) Gang Chen et al. BMC Medicine
- Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
- (2012) Xiao-Feng Le et al. PLoS One
- Experimentelle Tumortherapie
- (2012) M. Baumann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN- Production
- (2011) A. C. Jaime-Ramirez et al. JOURNAL OF IMMUNOLOGY
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
- (2011) Carlos A Fedrigo et al. Radiation Oncology
- Cetuximab Insufficiently Inhibits Glioma Cell Growth Due to Persistent EGFR Downstream Signaling
- (2010) Benedikte Hasselbalch et al. CANCER INVESTIGATION
- MAb 806 Enhances the Efficacy of Ionizing Radiation in Glioma Xenografts Expressing the de2-7 Epidermal Growth Factor Receptor
- (2010) Terrance G. Johns et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of STAT3 and ErbB2 Suppresses Tumor Growth, Enhances Radiosensitivity, and Induces Mitochondria-Dependent Apoptosis in Glioma Cells
- (2010) Ling Gao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells
- (2010) Antje Hahnel et al. Radiation Oncology
- Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
- (2009) A Diaz Miqueli et al. BRITISH JOURNAL OF CANCER
- Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status
- (2009) R L Rego et al. BRITISH JOURNAL OF CANCER
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
- (2009) B. Mukherjee et al. CANCER RESEARCH
- HER2-Positive Early Breast Cancer and Trastuzumab: A Surgeon’s Perspective
- (2008) Swati Kulkarni et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
- (2008) Volker Heinemann et al. CANCER TREATMENT REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search